Incidence and outcome of infection by vancomycin-resistant Enterococcus following orthotopic liver transplantation

K A Newell1, J M Millis, P M Arnow

  • 1Department of Surgery, University of Chicago, Illinois 60637, USA.

Transplantation
|March 4, 1998
PubMed

Insights

Vancomycin-resistant Enterococcus (VRE) infections are a serious threat after liver transplants, affecting 10.5% of patients. Biliary complications and previous antibiotic use significantly increase VRE risk, leading to high mortality.

Area of Science:

  • Infectious Diseases
  • Hepatology
  • Critical Care Medicine

Background:

  • Vancomycin-resistant Enterococcus (VRE) is a growing nosocomial pathogen.
  • Orthotopic liver transplantation (OLT) patients are susceptible to healthcare-associated infections.
  • VRE poses a significant challenge due to limited treatment options.

Purpose of the Study:

  • To determine the incidence of VRE infections post-OLT.
  • To identify risk factors associated with VRE infection in OLT recipients.
  • To analyze the outcomes and mortality related to VRE infections in this population.

Main Methods:

  • Retrospective review of 325 OLT patient records.
  • Analysis of patient demographics, comorbidities, and treatment history.
  • Comparison of VRE-infected patients with uninfected controls.

Main Results:

  • VRE infection incidence was 10.5% (14% adults vs. 5% children).
  • Key risk factors included prior antibiotic use (especially vancomycin), co-infections, relaparotomy, and biliary complications (OR 7.7).
  • VRE infection was associated with significantly higher mortality (56% vs. 19%) primarily due to sepsis.

Conclusions:

  • Biliary complications are a major risk factor for VRE infection post-OLT.
  • VRE infections contribute significantly to mortality in OLT patients.
  • Early surgical management of complications may reduce VRE risk.

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...